Our study found that there was an upstream and downstream regulatory relationship between NUP155 and NDC1, which were key nucleoporin proteins in the nuclear pore complex, and inhibiting the expression of NUP155 and NDC1 could inhibit the malignant progression of NSCLC cells. The gene discussed is NDC1; the disease is non-small cell lung carcinoma.